دورية أكاديمية
أعرض في EDS

Ephedra alata subsp. alenda (Ephedraceae) leaf extracts: phytochemical screening, anti-diabetic, anti-obesity and anti-toxic activities on diabetic-induced liver-kidney-testes toxicities and inhibition of α-amylase and lipase enzymes.

التفاصيل البيبلوغرافية
العنوان: Ephedra alata subsp. alenda (Ephedraceae) leaf extracts: phytochemical screening, anti-diabetic, anti-obesity and anti-toxic activities on diabetic-induced liver-kidney-testes toxicities and inhibition of α-amylase and lipase enzymes.
المؤلفون: Saidi SA; Department of Biology, College of Sciences and Arts-Khulis, University of Jeddah, Jeddah, Saudi Arabia., Al-Shaikh TM; Department of Biology, College of Sciences and Arts-Khulis, University of Jeddah, Jeddah, Saudi Arabia., Alghamdi OA; Department of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia., Hamden K; Laboratory of Bioresources: Integrative Biology and Exploiting, Higher Institute of Biotechnology of Monastir, University of Monastir, Tunisia.
المصدر: Heliyon [Heliyon] 2022 Nov 29; Vol. 8 (12), pp. e11954. Date of Electronic Publication: 2022 Nov 29 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: London : Elsevier Ltd, [2015]-
مستخلص: The study evaluated the phytochemical composition of Ephedra alata and its effects on α-amylase and lipase enzymes and diabetic-induced liver-kidney-testes toxicities to determine the anti-diabetic, anti-obesity, and anti-toxic potentials of the plant. Obesity was induced by a high-fat and fructose diet (HFFD). Various compounds were identified and quantified: cafeic acid, apigenin 7-O-glucoside, apigenin, rutin, luteolin 7-O-glucoside, p-Coumaric acid and others in EA aqueous extract (EAWE). In vitro , this study showed that EAWE strongly inhibited lipase activity as compared to EA methanol (EAME) and ethyl acetate EA extracts (EAEE). In obese rats, the supplementation of EAWE inhibited significantly (P < 0.01) intestinal and pancreatic lipase activity by 35 and 36% respectively. This decrease in lipid digestive enzyme activity caused a significant (P < 0.05) reduce in the weight gain by 12.7% and significant (P < 0.05) decrease in the serum lipid rate as total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). Moreover, the supplementation of EAWE to obese rats reduced the activity of α-amylase in the small intestine and pancreas by 26 and 31% respectively (P < 0.01) and consequently decreases in serum glucose level by 20.8% (P < 0.05). In addition, administration of EAWE in type 2 diabetes protected from obesity induced liver, kidney and testes alterations. The potent protective effect EAWE may be influenced by the diversity of phenolic compounds. therefore, this study showed in the first time that EAWE are efficient for the prevention and the amelioration of obesity, hyperglycemia, and various organs toxicities.
Competing Interests: The authors declare no conflict of interest.
(© 2022 The Author(s).)
References: J Prev Med Public Health. 2020 Mar;53(2):98-105. (PMID: 32268464)
Can J Physiol Pharmacol. 2016 Jun;94(6):651-61. (PMID: 27089006)
BMC Chem. 2021 Jun 26;15(1):41. (PMID: 34174945)
Heliyon. 2018 Sep 27;4(9):e00810. (PMID: 30294692)
Biomed Pharmacother. 2020 Aug;128:110314. (PMID: 32485574)
Nat Prod Res. 2022 Nov;36(22):5910-5915. (PMID: 35019791)
Heliyon. 2021 Jul 31;7(8):e07702. (PMID: 34401583)
Heliyon. 2019 Sep 12;5(9):e02453. (PMID: 31538117)
Heliyon. 2019 May 07;5(5):e01634. (PMID: 31193002)
Exp Gerontol. 2020 Feb 19;134:110881. (PMID: 32084535)
Arch Physiol Biochem. 2022 Dec;128(6):1453-1460. (PMID: 32536285)
PLoS One. 2018 Apr 11;13(4):e0195502. (PMID: 29641549)
Gut Pathog. 2022 Jul 6;14(1):30. (PMID: 35794638)
J Basic Clin Physiol Pharmacol. 2015 Mar;26(2):165-70. (PMID: 24825096)
Proc Natl Acad Sci U S A. 1970 Feb;65(2):383-7. (PMID: 4313197)
Heliyon. 2021 Nov 25;7(11):e08404. (PMID: 34901489)
Molecules. 2021 May 28;26(11):. (PMID: 34071554)
Chem Biol Interact. 2009 Aug 14;180(3):421-32. (PMID: 19393637)
Heliyon. 2020 Aug 21;6(8):e04736. (PMID: 32904229)
Pharmacol Res. 2020 Feb;152:104586. (PMID: 31877350)
Food Res Int. 2021 May;143:110240. (PMID: 33992352)
J Diabetes Res. 2021 Mar 17;2021:6659415. (PMID: 33816636)
Sultan Qaboos Univ Med J. 2016 May;16(2):e132-41. (PMID: 27226903)
Int J Mol Sci. 2021 Jan 31;22(3):. (PMID: 33572687)
Heliyon. 2019 Nov 21;5(11):e02800. (PMID: 31844729)
Clin Pharmacol Drug Dev. 2021 Oct;10(10):1242-1247. (PMID: 33580745)
Heliyon. 2021 Jun 21;7(6):e07363. (PMID: 34222697)
Drug Chem Toxicol. 2021 Jul;44(4):341-352. (PMID: 30907158)
J Anim Physiol Anim Nutr (Berl). 2022 Jul;106(4):872-880. (PMID: 34596925)
Chin J Traumatol. 2017 Apr;20(2):108-113. (PMID: 28209447)
Toxicol Rep. 2022 Mar 29;9:699-712. (PMID: 35433275)
Biomed Res Int. 2019 May 23;2019:4851279. (PMID: 31240213)
Obes Res Clin Pract. 2018 Jan - Feb;12(Suppl 2):115-126. (PMID: 27161420)
Arch Physiol Biochem. 2019 Dec;125(5):423-429. (PMID: 29898610)
FASEB J. 2020 Jun;34(6):7810-7824. (PMID: 32350925)
Heliyon. 2020 Nov 06;6(11):e05408. (PMID: 33204882)
Saudi J Biol Sci. 2022 Feb;29(2):1021-1028. (PMID: 35197771)
Pharm Biol. 2022 Dec;60(1):1384-1393. (PMID: 35938503)
Br J Nutr. 2007 Oct;98(4):720-6. (PMID: 17666145)
J Sci Food Agric. 2021 Mar 15;101(4):1598-1608. (PMID: 32875596)
Crit Rev Food Sci Nutr. 2018 Jan 22;58(2):262-296. (PMID: 27127938)
Food Res Int. 2017 Jan;91:11-17. (PMID: 28290314)
Heliyon. 2021 Mar 17;7(3):e06539. (PMID: 33817385)
Food Chem Toxicol. 2014 Dec;74:320-25. (PMID: 25445758)
J Agric Food Chem. 2009 Jan 28;57(2):425-31. (PMID: 19119847)
Food Nutr Res. 2014 Jul 10;58:. (PMID: 25045347)
EBioMedicine. 2016 Jul;9:61-76. (PMID: 27374313)
Food Res Int. 2019 Feb;116:312-319. (PMID: 30716951)
Heliyon. 2022 May 02;8(5):e09360. (PMID: 35600433)
Biomed Pharmacother. 2020 Jun;126:110079. (PMID: 32200256)
Heliyon. 2021 Apr 02;7(4):e06648. (PMID: 33889775)
Foods. 2022 Jan 06;11(2):. (PMID: 35053877)
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211036669. (PMID: 34350806)
Molecules. 2018 Dec 20;24(1):. (PMID: 30577537)
فهرسة مساهمة: Keywords: Ephedra alata; Kidney; Liver; Obesity; Testes; Type 2 diabetes
تواريخ الأحداث: Date Created: 20221208 Latest Revision: 20221210
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9720601
DOI: 10.1016/j.heliyon.2022.e11954
PMID: 36478797
قاعدة البيانات: MEDLINE
الوصف
تدمد:2405-8440
DOI:10.1016/j.heliyon.2022.e11954